Skip to content

deCOMPressing stomA and two-Stage elective resection vs. emergency reSection in patients with left-sided obstructive colon cancer

deCOMPressing stomA and two-Stage elective resection vs. emergency reSection in patients with left-sided obstructive colon cancer - COMPASS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031827
Enrollment
468
Registered
2023-05-15
Start date
2023-12-07
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C18

Interventions

Group 1: Accomplishment of a decompressing stoma followed by a two-stage oncological elective resection after convalescence Group 2: Emergency resection of the left-sided obstructive colon tumor

Sponsors

Technische Universität Dresden
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Colonic obstruction of patients with a left-sided colon or upper rectal tumor (splenic flexure to the intraperitoneal rectum (tumor > 12 cm from the anal verge)) treated with curative intent - the tumor must be highly suspicious for colon cancer in CT or endoscopy - proof of colonic dilatation by computed tomography - the tumor including potential metastases must be deemed curatively resectable - Capacity of the patient to consent

Exclusion criteria

Exclusion criteria: - Right-sided colon - Extraperitoneal rectal cancer of the lower and middle third (tumor < 12 cm from the anal verge) - life expectancy < 120 days due to advanced tumour disease - locally advanced tumor disease with local infiltration of other structures which excludes a R0 resection or requires a neoadjuvant treatment - patients treated in palliative intent - signs of bowel perforation on CT - patients not eligible for surgery (ASA Score = IV) - lack of compliance - Addiction or other illnesses which do not allow the person concerned to assess the nature and extent of the clinical trial and its possible consequences

Design outcomes

Primary

MeasureTime frame
Perioperative 120-day mortality

Secondary

MeasureTime frame
Patient reported quality of life (EORTC QLQ-C30), Primary anastomosis, 90-day complication rate, Permanent stoma rate after 1 year, comparison of number of resected lymph nodes, comparison of local R0 resection, 3-year overall survival, 3-year cancer-specific survival, 3-year disease-free survival, incisional hernia at 3-years, adjuvant therapy after resection and oncological re-interventions (due to recurrence), quality-adjusted survival (QALY)

Countries

Germany

Contacts

Public ContactChristoph Kahlert

Universitätsklinikum Heidelberg

Christoph.Kahlert@med.uni-heidelberg.de+49 6221 56310222

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 8, 2026